Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (AMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05666804
What this trial is testing

Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy

Who this might be right for
Macular Polypoidal Choroidal Vasculopathy (PCV)
Novartis Pharmaceuticals 148
Testing effectiveness (Phase 2)Study completedNCT02555306
What this trial is testing

A Phase I/II Safety, Tolerability, Immunogenicity, and Bioactivity Study of DE-122 Injectable Solution for Refractory Exudative Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Santen Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00733304
What this trial is testing

An Extension to Study MD7108240

Who this might be right for
Macular Degeneration
GlaxoSmithKline 42
Testing effectiveness (Phase 2)Study completedNCT04200248
What this trial is testing

A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 94
Post-approval studies (Phase 4)Study completedNCT01617148
What this trial is testing

Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept

Who this might be right for
Exudative Macular Degeneration
Rishi Singh 26
Large-scale testing (Phase 3)Ended earlyNCT03577899
What this trial is testing

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 1,157
Testing effectiveness (Phase 2)WithdrawnNCT00696592
What this trial is testing

Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
University of Padova
Testing effectiveness (Phase 2)Study completedNCT00729846
What this trial is testing

Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)

Who this might be right for
Age Related Macular DegenerationChoroidal NeovascularizationMacular Edema
California Retina Consultants 22
Early research (Phase 1)Study completedNCT03777254
What this trial is testing

Evaluation the Pharmacokinetics,Safety,Tolerability of Single Intravitreal Injection RC28-E in Subjects With Wet Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
RemeGen Co., Ltd. 12
Not applicableUnknownNCT05831007
What this trial is testing

Safety and Efficacy Study of LX102-C01 Treatment of Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 6
Post-approval studies (Phase 4)Study completedNCT01863199
What this trial is testing

Impact of Home Monitoring to Decrease the Treatment Burden for Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age Related Macular Degeneration
Retinal Consultants of Arizona 60
Early research (Phase 1)Study completedNCT03335852
What this trial is testing

Safety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Japanese Patients With Neovascular AMD

Who this might be right for
Macular Degeneration
Allergan 11
Large-scale testing (Phase 3)Study completedNCT01482910
What this trial is testing

VEGF Trap-Eye: Investigation of Efficacy and Safety in Chinese Subjects With Wet AMD (Age-Related Macular Degeneration)

Who this might be right for
Macular Degeneration
Bayer 304
Post-approval studies (Phase 4)Study completedNCT05832996
What this trial is testing

Cool vs Room-temperature Artificial Tears

Who this might be right for
Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis)Central Retinal Vein Occlusion With Macular EdemaExudative Age-Related Macular Degeneration, Unspecified Eye+4 more
University of Iowa 124
Testing effectiveness (Phase 2)Study completedNCT00805233
What this trial is testing

Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Oregon Health and Science University 30
Large-scale testing (Phase 3)Study completedNCT04005352
What this trial is testing

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 734
Not applicableStudy completedNCT06890026
What this trial is testing

Durability of Three Monthly Loading Doses With Faricimab in Treatment-naïve Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Treatment-naïve
Rigshospitalet, Denmark 742
Not applicableStudy completedNCT04138420
What this trial is testing

Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab

Who this might be right for
Exudative Age-related Macular Degeneration
Federico II University 38
Early research (Phase 1)Not Yet RecruitingNCT05611424
What this trial is testing

Gene Therapy for Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Frontera Therapeutics 18
Early research (Phase 1)Study completedNCT04370379
What this trial is testing

Trial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD Patients

Who this might be right for
Neovascular Age-related Macular Degeneration
Innovent Biologics (Suzhou) Co. Ltd. 18
Next Page